We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2023

Session

Sunday
May 14
16:45 - 17:45
Hall A
Gynaecology
Elena Manea, Romania;
Richard Pötter, Austria
Proffered Papers are presented in one of the sessions scheduled in the main session halls. Each author will present orally for 7 minutes, followed by 3 minutes for discussion. Sessions will be recorded and available on-demand.
Proffered Papers
Clinical
16:45 - 16:55
Early toxicity and quality of life after molecular-based adjuvant treatment in the PORTEC-4a trial
Anne-Sophie van den Heerik, The Netherlands
OC-0601
16:55 - 17:05
Development of an evidence-based adjuvant treatment decision support tool for endometrial cancer
Lisa Vermij, The Netherlands
OC-0602
17:05 - 17:15
Which is the optimal lymph node management in node positive cervical cancer?
Alexandru-Teodor Zaharie, Austria
OC-0603
17:15 - 17:25
HYPOCx-iRex (TCTR20210812003) a phase II RCT: 44Gy/20F VS 45Gy/25F CCRT in Cervical Cancer
Tissana Prasartseree, Thailand
OC-0604
17:25 - 17:35
Patient-reported peripheral neuropathy in cervix cancer patients: a trajectory analysis
Anders Tobias Frederiksen, Denmark
OC-0605
17:35 - 17:45
Severity and time-weighted gastrointestinal morbidity in cervix cancer: EMBRACE analysis with MOSES
Mayuri Charnalia, Denmark
OC-0606